DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 40 · September 2007 DOI: 10.1055/s-002-7034


25th Symposium of the AGNP
Munich, 3rd–6th October 2007

Chairs: Prof. Dr. W. Wolfgang Fleischhacker, Innsbruck, Dr. Werner Kadus, Karlsruhe
Abstracts (HTML) List of Authors
A153
Bartl, J.; Gruenblatt, E.; Gerlach, M.; Riederer, P.; Mori, T.; Ozawa, H.: Methylphenidate effects on cell growth and maturation in neuronal stem cells
A154
Hellwig-Brida, S.; Goldbeck, L.: Effects of methylphenidate on neuropsychological functioning of boys with ADHD
A155
Klose, N.; Gerwe, M.; Hargarter, L.; Czekalla, J.; Mattejat, F.: Quality of life of children with ADHD – prospective, multicenter non-interventional LECO-trial evaluating the impact on QOL, effectiveness and tolerability of OROS®-methylphenidate
A156
Röser, C.; Renner, T. J.; Walitza, S.; Dempfle, A.; Nguyen, T.; Romanos, M.; Jacob, C.; Reif, A.; Schäfer, H.; Gerlach, M.; Warnke, A.; Lesch, K. P.: GIRK2 – A novel candidate gene for attention deficit hyperactivity disorder
A157
Stollhoff, K.; Schauble, B.; Czekalla, J.; Klose, N.; Gerwe, M.: Treatment with extended-release methylphenidate (OROS®-MPH) in children with ADHD is associated with improvement in social functioning throughout the active day – results from an open-label, non-interventional trial
A158
Wöckel, L.; Koch, S.; Meyer-Keitel, A. E.; Zepf, F.; Schmidt, M. H.; Poustka, F.: Reduced intracellular platelet Ca2+ responses to serotonin in patients with anorexia and bulimia nervosa increase under antidepressant medication